Senti Biosciences Holdings, Inc. (SNTI) Return on equity 2022–2025
Senti Biosciences Holdings, Inc. (SNTI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1099.3%FY2025 · since FY2022: -45.7% → -1099.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1099.3% | -893.4 pp |
| FY2024 | -205.8% | -99.6 pp |
| FY2023 | -106.2% | -60.5 pp |
| FY2022 | -45.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice